Yuyu Pharma Appoints Park Noyong as CEO

Noyong Park, New CEO of Yuyu Pharma

Yuyu Pharma announced on the 2nd that it has carried out its regular promotions and appointments for 2023. In this personnel move, Park Noyong, Executive Director of the Management Support Headquarters, was newly appointed as CEO.

Yuyu Pharma operates under a dual CEO system with CEO Park and third-generation owner Yoo Wonsang. CEO Yoo oversees domestic and international research and development (R&D), sales and marketing, and new business development. Newly appointed CEO Park is in charge of overall management including finance, HR, public relations, compliance, IT, and production.

CEO Park Noyong, born in 1970, earned a master's degree in business administration from Warsaw School of Economics in Poland. He worked at Daewoo Group and management consulting firms before joining Yuyu Pharma in 2001, where he managed various departments such as planning, finance, PR/IR, IT, purchasing, and exports. He served as project manager for the relocation of the new factory in Jecheon, was responsible for the M&A of Yuyu Healthcare, and played a key role in establishing Yuyu Taejin Medicare. Since 2014, he has served as Chief Financial Officer (CFO), successfully securing multiple rounds of funding to ensure stable corporate operations, according to Yuyu Pharma.

CEO Park stated, "I will support the successful completion of the YP-P10 project, a new drug for dry eye disease currently in Phase 2 clinical trials in the U.S., and strive with a spirit of continuous self-renewal so that Yuyu Pharma, with its 82-year history, can step beyond Korea and become a global company. Through efficient and stable management based on selection and concentration, I will work together with all employees to ensure Yuyu Pharma continues as a century-old company."